Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 82.69 Million EUR | -27.07% |
| 2022 | 113.39 Million EUR | 20.69% |
| 2021 | 93.96 Million EUR | -57.69% |
| 2020 | 222.07 Million EUR | 196.74% |
| 2019 | 74.83 Million EUR | 127.6% |
| 2018 | 32.88 Million EUR | -75.02% |
| 2017 | 131.64 Million EUR | 172.18% |
| 2016 | 48.36 Million EUR | -46.2% |
| 2015 | 89.9 Million EUR | -44.93% |
| 2014 | 163.26 Million EUR | -10.54% |
| 2013 | 182.49 Million EUR | -15.23% |
| 2012 | 215.28 Million EUR | -9.64% |
| 2011 | 238.26 Million EUR | -6.99% |
| 2010 | 256.17 Million EUR | 82.02% |
| 2009 | 140.73 Million EUR | -75.31% |
| 2008 | 570.07 Million EUR | 10.77% |
| 2007 | 514.65 Million EUR | 815.04% |
| 2006 | 56.24 Million EUR | 422.03% |
| 2005 | 10.77 Million EUR | -87.91% |
| 2004 | 89.14 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 62.55 Million EUR | 9.82% |
| 2024 Q1 | 91.38 Million EUR | 10.5% |
| 2023 Q4 | 82.69 Million EUR | 13.2% |
| 2023 Q1 | 93.47 Million EUR | -17.57% |
| 2023 Q3 | 73.05 Million EUR | -29.11% |
| 2023 Q2 | 103.05 Million EUR | 10.24% |
| 2023 FY | 82.69 Million EUR | -27.07% |
| 2022 Q3 | 104.34 Million EUR | -1.16% |
| 2022 Q4 | 113.39 Million EUR | 8.67% |
| 2022 FY | 113.39 Million EUR | 20.69% |
| 2022 Q1 | 97.15 Million EUR | 3.4% |
| 2022 Q2 | 105.56 Million EUR | 8.66% |
| 2021 Q2 | 226.86 Million EUR | 4.06% |
| 2021 Q3 | 85.71 Million EUR | -62.22% |
| 2021 Q1 | 218 Million EUR | -1.83% |
| 2021 Q4 | 93.96 Million EUR | 9.62% |
| 2021 FY | 93.96 Million EUR | -57.69% |
| 2020 Q1 | 178.1 Million EUR | 137.99% |
| 2020 Q3 | 212.46 Million EUR | 12.69% |
| 2020 Q2 | 188.53 Million EUR | 5.86% |
| 2020 FY | 222.07 Million EUR | 196.74% |
| 2020 Q4 | 222.07 Million EUR | 4.52% |
| 2019 Q1 | 30.8 Million EUR | -6.31% |
| 2019 Q3 | 65.11 Million EUR | 62.63% |
| 2019 Q2 | 40.03 Million EUR | 29.98% |
| 2019 FY | 74.83 Million EUR | 127.6% |
| 2019 Q4 | 74.83 Million EUR | 14.93% |
| 2018 Q3 | 32.88 Million EUR | -80.79% |
| 2018 Q1 | 171.14 Million EUR | 30.0% |
| 2018 FY | 32.88 Million EUR | -75.02% |
| 2018 Q4 | 32.88 Million EUR | -0.0% |
| 2018 Q2 | 171.14 Million EUR | 0.0% |
| 2017 Q2 | 112.7 Million EUR | 0.0% |
| 2017 Q1 | 112.7 Million EUR | 133.01% |
| 2017 FY | 131.64 Million EUR | 172.18% |
| 2017 Q4 | 131.64 Million EUR | 0.0% |
| 2017 Q3 | 131.64 Million EUR | 16.81% |
| 2016 Q1 | 102.81 Million EUR | 14.36% |
| 2016 FY | 48.36 Million EUR | -46.2% |
| 2016 Q4 | 48.36 Million EUR | 0.0% |
| 2016 Q3 | 48.36 Million EUR | -52.96% |
| 2016 Q2 | 102.81 Million EUR | 0.0% |
| 2015 Q3 | 97.14 Million EUR | -11.77% |
| 2015 Q4 | 89.9 Million EUR | -7.45% |
| 2015 Q2 | 110.1 Million EUR | -14.16% |
| 2015 FY | 89.9 Million EUR | -44.93% |
| 2015 Q1 | 128.27 Million EUR | -21.43% |
| 2014 Q3 | 158.88 Million EUR | -4.33% |
| 2014 Q4 | 163.26 Million EUR | 2.76% |
| 2014 Q1 | 207.52 Million EUR | 13.72% |
| 2014 FY | 163.26 Million EUR | -10.54% |
| 2014 Q2 | 166.06 Million EUR | -19.98% |
| 2013 Q4 | 182.49 Million EUR | 1.0% |
| 2013 FY | 182.49 Million EUR | -15.23% |
| 2013 Q3 | 180.69 Million EUR | -10.01% |
| 2013 Q2 | 200.79 Million EUR | -8.9% |
| 2013 Q1 | 220.41 Million EUR | 2.38% |
| 2012 Q2 | 230.98 Million EUR | -5.02% |
| 2012 Q4 | 215.28 Million EUR | -3.81% |
| 2012 FY | 215.28 Million EUR | -9.64% |
| 2012 Q1 | 243.18 Million EUR | 2.06% |
| 2012 Q3 | 223.82 Million EUR | -3.1% |
| 2011 FY | 238.26 Million EUR | -6.99% |
| 2011 Q1 | 268.19 Million EUR | 4.69% |
| 2011 Q2 | 240.29 Million EUR | -10.4% |
| 2011 Q3 | 239.38 Million EUR | -0.38% |
| 2011 Q4 | 238.26 Million EUR | -0.46% |
| 2010 FY | 256.17 Million EUR | 82.02% |
| 2010 Q1 | -3.21 Million EUR | -102.29% |
| 2010 Q2 | -41.64 Million EUR | -1194.56% |
| 2010 Q4 | 256.17 Million EUR | 987.2% |
| 2010 Q3 | -28.87 Million EUR | 30.67% |
| 2009 Q4 | 140.73 Million EUR | 0.0% |
| 2009 FY | 140.73 Million EUR | -75.31% |
| 2008 FY | 570.07 Million EUR | 10.77% |
| 2007 FY | 514.65 Million EUR | 815.04% |
| 2006 FY | 56.24 Million EUR | 422.03% |
| 2005 FY | 10.77 Million EUR | -87.91% |
| 2004 FY | 89.14 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -17142.213% |
| Ansell Limited | -54.99 Million USD | 250.37% |
| Ansell Limited | -55.1 Million USD | 250.089% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 326.615% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 78784.516% |
| Psykey, Inc. | 634.59 Thousand USD | -12931.817% |
| ConvaTec Group Plc | 1.2 Billion USD | 93.112% |
| ConvaTec Group Plc | 1.2 Billion USD | 93.122% |
| Encision Inc. | 1.29 Million USD | -6307.333% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -3482.033% |
| Innovative MedTech Inc. | 1.76 Million USD | -4586.197% |
| LifePoint, Inc. | -3.26 Million USD | 2633.654% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -1586.295% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -3725.116% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 191073.12% |
| Reflect Scientific, Inc. | -1.03 Million USD | 8087.872% |
| SmileDirectClub, Inc. | 778.67 Million USD | 89.38% |
| Sector 10, Inc. | 163 Thousand USD | -50635.583% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 119.806% |
| SheerVision, Inc. | 57.34 Thousand USD | -144103.038% |
| United Health Products, Inc. | 660.56 Thousand USD | -12419.358% |
| Vasamed, Inc. | 22.12 Thousand USD | -373731.48% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -3042.992% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -10608.436% |